ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag photography infectious disease cell molecular biology biodiversity culture

Sino Biological Deposits Recombinant Omicron Proteins and Antibodies to BEI Resources
Sino Biological Deposits Recombinant Omicron Proteins and Antibodies to BEI Resources
Sino Biological | Dec 31, 2021 | 2 min read
Sino Biological, Inc. (SZSE: 301047) has recently deposited reagents for the Omicron variant, including recombinant proteins to Spike and Nucleocapsid, and antibody products to BEI Resources, a central repository for reagents to support infectious disease research.
Better Understanding Of Cell's Life Eases Culturing
Ricki Lewis | Nov 13, 1994 | 10+ min read
"Lots of companies come out with media or reagents for this or that, and make a big splash, but they're all basically derivatives of traditional products," says Hayden Coon, a former National Institutes of Health re-searcher who is the founder of Human Cell Therapies Inc. of Chebeague Island, Maine. Advanced Biotechnologies Inc. Columbia, MD American Qualex Antibodies La Mirada, CA American Type Culture Collection (ATCC) Rockv
Better Understanding Of Cell's Life Eases Culturing
Ricki Lewis | Nov 13, 1994 | 10+ min read
"Lots of companies come out with media or reagents for this or that, and make a big splash, but they're all basically derivatives of traditional products," says Hayden Coon, a former National Institutes of Health re-searcher who is the founder of Human Cell Therapies Inc. of Chebeague Island, Maine. Advanced Biotechnologies Inc. Columbia, MD American Qualex Antibodies La Mirada, CA American Type Culture Collection (ATCC) Rockv
2022 Top 10 Innovations 
2022 Top 10 Innovations
The Scientist | Dec 12, 2022 | 10+ min read
This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.
Researchers Plumb Depths To Fight A Wide Array Of Human Diseases
Karen Kreeger | Sep 18, 1994 | 9 min read
Meeting Grounds For Marine Biotechnologists For more information on marine natural products and pharmaceuticals, contact: American Society for Microbiology 1325 Massachusetts Ave., N.W. Washington, D.C. 20005-4171 Phone: (202) 737-3600 Fax: (202) 942-9340 (For the appropriate E-mail address, call the above number.) Michael Goldberg, Executive Director David Schlessinger, president American Society for Molecular Marine Biology a
Researchers Plumb Depths To Fight A Wide Array Of Human Diseases
Karen Kreeger | Sep 18, 1994 | 9 min read
Meeting Grounds For Marine Biotechnologists For more information on marine natural products and pharmaceuticals, contact: American Society for Microbiology 1325 Massachusetts Ave., N.W. Washington, D.C. 20005-4171 Phone: (202) 737-3600 Fax: (202) 942-9340 (For the appropriate E-mail address, call the above number.) Michael Goldberg, Executive Director David Schlessinger, president American Society for Molecular Marine Biology a
2020 Top 10 Innovations
The Scientist | Dec 1, 2020 | 10+ min read
From a rapid molecular test for COVID-19 to tools that can characterize the antibodies produced in the plasma of patients recovering from the disease, this year’s winners reflect the research community’s shared focus in a challenging year.
Antibody Alternatives
Paul Ko Ferrigno and Jane McLeod | Feb 1, 2016 | 10+ min read
Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.
Sizing up Nanoparticles
Kelly Rae Chi | Apr 1, 2010 | 6 min read
By Kelly Rae Chi Sizing up Nanoparticles How to put nanoparticles to work in drug development. Nanoparticles are increasingly found in drug development. Researchers are using them in designing treatments for tumors, infections, and brain diseases, as well as for imaging techniques that enhance visualization of molecular-scale events in brain tissue and culture dishes. But so far, says biochemist Michael Sailor of the University of Californi
Recent Trials for Fragile X Syndrome Offer Hope
Randi Hagerman | Sep 1, 2019 | 10+ min read
Despite a solid understanding of the biological basis of fragile X syndrome, researchers have struggled to develop effective treatments.

Run a Search

ADVERTISEMENT